<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Ridgeback Biotherapeutics Feed]]></title>
        <description><![CDATA[Ridgeback Biotherapeutics articles]]></description>
        <link>https://sps.devopsroom.com</link>
        <generator>sps.ro</generator>
        <lastBuildDate>Wed, 17 Jun 2026 15:59:17 GMT</lastBuildDate>
        <atom:link href="https://sps.devopsroom.com/tag/ridgeback-biotherapeutics/feed" rel="self" type="application/rss+xml"/>
        <pubDate>Wed, 17 Jun 2026 15:59:17 GMT</pubDate>
        <language><![CDATA[ro-RO]]></language>
        <item>
            <title><![CDATA[Merck recunoaște că pastila-minune anti-COVID-19 nu este atât de eficientă pe cât se anunța]]></title>
            <description><![CDATA[Grupul farmaceutic Merck a anunţat vineri că o serie de date actualizate ale studiului său privind o pastilă experimentală anti-COVID-19 au arătat că acest medicament este mai puţin eficient în privinţa spitalizărilor şi a deceselor decât au sugerat ...]]></description>
            <link>https://sps.devopsroom.com/molnupiravir_2115635.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/molnupiravir_2115635.html</guid>
            <category><![CDATA[stiripesurse.ro]]></category>
            <category><![CDATA[stiripesurse]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[pastila]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[Agenţia americană pentru Alimente şi Medicamente]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[pastilă anti-COVID-19]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[pastilă experimentală anti-COVID-19]]></category>
            <category><![CDATA[pastila Merck]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Fri, 26 Nov 2021 15:25:30 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163309371611317400.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[Guvernul SUA va plăti 1 miliard de dolari pentru doze suplimentare de pastile anti-COVID-19 produse de Merck]]></title>
            <description><![CDATA[Guvernul Statelor Unite va plăti încă 1 miliard de dolari pentru a cumpăra doze suplimentare de pastile anti-COVID-19 produse de grupul farmaceutic Merck şi partenerul său Ridgeback Biotherapeutics, au anunţat marţi cele două companii, citate de Reut...]]></description>
            <link>https://sps.devopsroom.com/guvernul-sua-va-plati-1-miliard-de-dolari-pentru-doze-suplimentare-de-pastile-anti-covid-19-produse-de-merck_2087455.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/guvernul-sua-va-plati-1-miliard-de-dolari-pentru-doze-suplimentare-de-pastile-anti-covid-19-produse-de-merck_2087455.html</guid>
            <category><![CDATA[Statele Unite]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[Pfizer]]></category>
            <category><![CDATA[COVID-19]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[Frank Clyburn]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <category><![CDATA[Tarom AirFi]]></category>
            <dc:creator><![CDATA[Anca-Adriana Huza]]></dc:creator>
            <pubDate>Tue, 09 Nov 2021 16:25:28 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163309371611317400.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[Merck anunță un acord pentru acces global la pastila sa anti-COVID-19]]></title>
            <description><![CDATA[Grupul farmaceutic american Merck a anunţat miercuri un acord care ar putea să permită difuzarea pe scară largă în ţările sărace a unor versiuni generice ale pastilei sale anti-COVID-19, concepută pentru tratarea persoanelor infectate cu noul coronav...]]></description>
            <link>https://sps.devopsroom.com/merck-anunta-un-acord-pentru-acces-global-la-pastila-sa-anti-covid-19_2066929.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/merck-anunta-un-acord-pentru-acces-global-la-pastila-sa-anti-covid-19_2066929.html</guid>
            <category><![CDATA[SUA]]></category>
            <category><![CDATA[ONU]]></category>
            <category><![CDATA[stiripesurse.ro]]></category>
            <category><![CDATA[OMS]]></category>
            <category><![CDATA[Geneva]]></category>
            <category><![CDATA[Organizaţia Mondială a Sănătăţii]]></category>
            <category><![CDATA[stiripesurse]]></category>
            <category><![CDATA[miami]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[COVID-19]]></category>
            <category><![CDATA[msd]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[Medicines Patent Pool]]></category>
            <category><![CDATA[pastilă anti-COVID-19]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[Wendy Holman]]></category>
            <category><![CDATA[MPP]]></category>
            <category><![CDATA[Charles Gore]]></category>
            <category><![CDATA[Știrile Zilei]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Wed, 27 Oct 2021 17:43:34 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163309371611317400.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[OMS anunță care sunt pastilele ce pot învinge COVID-19: 'O nouă armă de luptă împotriva pandemiei']]></title>
            <description><![CDATA[Organizaţia Mondială a Sănătăţii (OMS) a anunţat marţi că studiază datele privind eficacitatea Molnupiravir, un medicament oral sub formă de pastile anti-COVID-19 dezvoltat de compania farmaceutică germană Merck, subliniind că "ar putea fi o nouă arm...]]></description>
            <link>https://sps.devopsroom.com/oms-anunta-care-sunt-pastilele-ce-pot-invinge-covid-19-o-noua-arma-de-lupta-impotriva-pandemiei_2042214.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/oms-anunta-care-sunt-pastilele-ce-pot-invinge-covid-19-o-noua-arma-de-lupta-impotriva-pandemiei_2042214.html</guid>
            <category><![CDATA[OMS]]></category>
            <category><![CDATA[pacienti]]></category>
            <category><![CDATA[medicament]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[MSF]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[Organizaţia Medici fără Frontiere]]></category>
            <category><![CDATA[COVID-19]]></category>
            <category><![CDATA[Christian Lindmeier]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[Știrile Zilei]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <category><![CDATA[Tarom AirFi]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Tue, 12 Oct 2021 14:51:20 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202106/1600x900/media-162256185643686200.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[ULTIMA ORĂ A fost făcută cerere de autorizare în regim de urgență a medicamentului anti-COVID-19]]></title>
            <description><![CDATA[Laboratorul american Merck a anunţat luni că a depus la Agenţia pentru Alimente şi Medicamente din Statele Unite (FDA) o cerere de autorizare în regim de urgenţă a pastilei sale anti-COVID-19 care, potrivit unui studiu clinic, reduce cu aproximativ 5...]]></description>
            <link>https://sps.devopsroom.com/ultima-ora-a-fost-facuta-cerere-de-autorizare-in-regim-de-urgenta-a-medicamentului-anti-covid-19_2039884.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/ultima-ora-a-fost-facuta-cerere-de-autorizare-in-regim-de-urgenta-a-medicamentului-anti-covid-19_2039884.html</guid>
            <category><![CDATA[stiripesurse.ro]]></category>
            <category><![CDATA[stiripesurse]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[pastilă anti-COVID-19]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[Agenţia pentru Alimente şi Medicamente din Statele Unite]]></category>
            <category><![CDATA[Știrile Zilei]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Mon, 11 Oct 2021 13:09:48 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163309371611317400.webp" length="0" type="image/webp"/>
        </item>
        <item>
            <title><![CDATA[Studiu: Pastila experimentală anti-COVID-19 dezvoltată de americani reduce riscul de deces şi de spitalizare cu 50%]]></title>
            <description><![CDATA[Molnupiravir, un medicament experimental anti-COVID-19 cu administrare orală dezvoltat de Merck &amp; Co Inc, a redus cu aproximativ 50% riscul de spitalizare şi de deces pentru pacienţii predispuşi la forme severe ale acestei maladii, potrivit rezul...]]></description>
            <link>https://sps.devopsroom.com/studiu-pastila-experimentala-anti-covid-19-dezvoltata-de-americani-reduce-riscul-de-deces-si-de-spitalizare-cu-50prc-_2023519.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/studiu-pastila-experimentala-anti-covid-19-dezvoltata-de-americani-reduce-riscul-de-deces-si-de-spitalizare-cu-50prc-_2023519.html</guid>
            <category><![CDATA[medicament]]></category>
            <category><![CDATA[Statele Unite]]></category>
            <category><![CDATA[tratament]]></category>
            <category><![CDATA[fda]]></category>
            <category><![CDATA[Merck]]></category>
            <category><![CDATA[COVID-19]]></category>
            <category><![CDATA[SARS-CoV-2]]></category>
            <category><![CDATA[molnupiravir]]></category>
            <category><![CDATA[Ridgeback Biotherapeutics]]></category>
            <category><![CDATA[Merck & Co Inc]]></category>
            <category><![CDATA[Robert Davis]]></category>
            <category><![CDATA[Roche Holding AG]]></category>
            <category><![CDATA[Wendy Holman]]></category>
            <category><![CDATA[Știrile Zilei]]></category>
            <category><![CDATA[Externe]]></category>
            <category><![CDATA[Sănătate]]></category>
            <category><![CDATA[Instant Articles]]></category>
            <category><![CDATA[Stiri TV]]></category>
            <category><![CDATA[Blitz TV]]></category>
            <category><![CDATA[Parteneri Articole]]></category>
            <category><![CDATA[Tarom AirFi]]></category>
            <dc:creator><![CDATA[Cristi Șelaru, Redactor]]></dc:creator>
            <pubDate>Fri, 01 Oct 2021 16:06:24 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202110/1600x900/media-163309371611317400.webp" length="0" type="image/webp"/>
        </item>
    </channel>
</rss>